Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP1715890

CTGF AS TARGET FOR THE THERAPY OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    11.2.2005
  • EP published:
    9.7.2008
  • EP application number:
    05713358.9
  • Max expiry date:
    10.2.2025
  • Title:
    CTGF AS TARGET FOR THE THERAPY OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY

Timeline

Today
11.2.2005EP application
9.7.2008EP Publication

Owner

  • Name:
    FIBROGEN, INC.
  • Address:
    225 Gateway Boulevard, South San Francisco, CA 94080, US

Inventor

  • Name:
    FLYVBJERG, Allan
  • Address:
    Odder, DK
  • Name:
    GUO, Guangjie
  • Address:
    Foster City, CA 94404, US
  • Name:
    LIU, David, Y.
  • Address:
    Palo Alto, CA 94306, US
  • Name:
    NEFF, Thomas, B.
  • Address:
    Atherton, CA 94027, US
  • Name:
    OLIVER, Noelynn, A.
  • Address:
    Los Altos, CA 94022, US
  • Name:
    USINGER, William, R.
  • Address:
    Lafayette, CA 94549, US
  • Name:
    WANG, Qingjian
  • Address:
    Belmont, CA 94002, US

Priority

  • Number:
    544121 P
  • Date:
    11.2.2004
  • Country:
    US
  • Number:
    561018 P
  • Date:
    8.4.2004
  • Country:
    US
  • Number:
    578401 P
  • Date:
    9.6.2004
  • Country:
    US
  • Number:
    620802 P
  • Date:
    20.10.2004
  • Country:
    US

Upload documents